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The success of orthotopic liver transplantation 
(OLTx) has greatly improved since the introduction of 
cyclosporine in 1980. Many young patients are given 
a second chance at life, and with this comes the 
restoration of menstrual abnormalities and the 
possibility of pregnancy (1, 2) Since the first 
/J//3 
successful pregnancy in a liver transplant patient 
took place in 1976 (3, 4), a total of 29 babies have 
been born to 22 liver transplant recipients from the 
combined programs of the University of Colorado and 
the University of Pittsburgh. The complications and 
outcome of these pregnancies are reviewed and the 
effect on hepatic function is analyzed. 
Background 
Four patients underwent OLTx at the University of 
Colorado prior to 1980, while 18 patients received 
their liver transplantations at the University of 
pittsburgh between 1983 and 1990. The indications for 
transplantation consisted primarily of chronic active 
hepatitis (10 patients) and fulminant hepatitis (3 
patients). Two were transplanted for alpha-l 
antitrypsin deficiency and sclerosing cholangitis, 
while biliary atresia, Wilson's disease, Caroli' s 
disease, primary biliary cirrhosis, secondary biliary 
cirrhosis and Budd-Chiari Syndrome were the 
indications in one case each. Immunosuppression 
consisted of combinations of prednisone, azathioprine 
and/or cyclosporine in all but one patient who 
received the new immunosuppressive drug FK506 and 
prednisone. Two patients were switched from 
cyclosporine to FK506 1.2 and 6.5 years later. 
One patient was transplanted acutely for fulminant 
hepatic failure during pregnancy, presenting at 26 
weeks gestation (5). All others conceived between 3 
weeks and 11 1/2 years after transplantation (Table 
1) • 
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TABLE I 
CONCEPTION TIME AFTER TRANSPLANTATION 
NO. OF PATIENTS 
WITHIN FIRST YEAR 
0-6 MONTHS 
6-12 MONTHS 
WITHIN 1 TO 3 YEARS 
AFTER 3 YEARS 
. . . . . . . . . . . . . . . . . . . . . . . .. 11 * 
3* 
7 
7 
5 
* One patient was 26 weeks pregnant at transplantation 
The patient who received FK506 and prednisone 
immediately after OLTx became pregnant wi thin 15 
months, but underwent an elective termination of 
pregnancy. This patient did not deliver any children 
after OLTx and therefore was not included in this 
study. Four other abortions after OLTx were reported: 
two patients each had a spontaneous abortion prior to 
successfully completing a pregnancy; one other had 2 
therapeutic abortions after a difficult pre-term 
delivery. 
Results 
Twenty-two recipients of orthotopic liver 
transplantation delivered 29 children, including 2 
sets of twins. Five patients each had 2 successful 
pregnancies. Eleven babies were born by normal 
spontaneous vaginal deliver (NSVD), 8 of which were 
full term babies; three were preterm (27%), delivered 
before 36 weeks gestational age. Mean birth weight 
in this group was 2660 grams. Fourteen of the 
remaining 16 deliveries performed by cesarean section 
resulted in preterm infants (88%), with a mean 
.......... ------
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gestational age of 32 weeks. The average birth weight 
for cesarean births was 1820 grams. Preeclampsia was 
seen in 5 patients, and was the cause of early 
delivery in 4 of these (3 by cesarean, 1 by NSVD). 
Premature rupture of membranes and fetal distress were 
also included as frequent causes of cesarean 
deliveries (3 each) . other less frequent 
precipitating factors were breech pres·entation (1), 
transverse lie (1), intrauterine growth retardation 
(1) and previous cesarean delivery (4). 
One repeated antepartum maternal complication seen 
was anemia, demonstrated in six patients (hemoglobin 
less than 10g/lb). Two patients were anemic from 
their first prenatal visit, and required red blood 
cell transfusions during and after their pregnancies. 
Progressive hypertension was seen in 2 patients, while 
recurrent urinary tract infection and pyelonephritis 
complicated the courses of 2 additional patients. 
The alterations in hepatic enzyme function seen in 
patients are summarized as seen in Table 2. Two 
patients had biopsy proven rejection in the first and 
third trimester of pregnancy. The first one underwent 
treatment with steroids for presumed acute rejection, 
a diagnosis later changed to chronic rejection. This 
patient continued to have elevated transaminase 
enzymes throughout pregnancy. The second patient was 
diagnosed with acute rej ection in the third trimester, 
biopsy also showing areas consistent with a hepatitic 
process. Treatment was withheld until after deliver, 
with near resolution of the abnormal transminases even 
before steroid therapy was initiated. A third biopsy 
performed in a patient with hepatitis B, was 
consistent with mild hepatitis in the second trimester 
of pregnancy. Four other patients had transaminase 
enzyme elevations in the antepartum period, and 
without treatment, resolved spontaneously in the 
immediate post-partum period. There were no reported 
changes in hepatic graft function in the remaining 
fifteen patients. 
Progressive increase in hepatic enzyme activity 
occurred in ten patients in the post-partum period, 
half of whom had stable hepatic function prior to 
delivery. Four patients were treated empirically with 
steroids, while four others underwent a liver biopsy 
and/or percutaneous transhepatic cholangiogram (PTC) . 
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TABLE II 
ALTERATIONS IN LIVER FUNCTIONS 
ANTEPARTUM 
STABLE 
ENZYME 
BIOPSY 
POST PARTUM 
FUNCTION ................ . 
ELEVATIONS ............... . 
15 
7 
3 
STABLE .............................. 12 
ENZYME ELEVATIONS ................... 10 
STEROID TREATMENT ................... 4 
BIOPSY AND/OR PTC* ................... 4 
SPONTANEOUS RESOLUTION .............. 3 
*PTC: Percutaneous Transhepatic Cholangiogram 
Two patients who had biopsies and PTC's had normal 
results; one was found to have ongoing hepatitis by 
biopsy. The fourth patient underwent a PTC after no 
improvement was seen with steroid treatment, and was 
found to have multiple biliary structures by 
cholangiogram. This patient had chronic rejection 
diagnosed in the first trimester, and underwent re-
transplantation within 2 months after delivery. 
Of the twenty-nine infants born to women who 
received liver transplantation, one was conceived 27 
weeks prior to an emergency OLTx for fulminant hepatic 
B. A second OLTx was required on post-op day 3 due 
to primary graft failure. As a result of multiple 
complications, a cesarean delivery was carried out 1 
week later, with subsequent death of the neonate. Of 
the remaining 28 babies conceived after 
transplantation, a second death occurred in an infant 
born at 26 weeks gestation, whose mother developed 
severe preeclampsia. This child died from presumed 
sepsis after becoming neutropenic (5). A third death 
occurred in a 7 month old infant born to a patient 10 
years after her transplant and 3 1/2 years after the 
birth of her first child (6).. A diagnosis for the 
human immunodeficiency virus infection was made in 
both mother and child, both of whom later succumbed 
to the complications of this virus infection. One 
other maternal death was reported in a 25 year old 
mother who developed B-cell lymphoma 2 1/2 years after 
the birth of her child (7). 
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other neonatal complications reported include 
intrauterine growth retardation (4) hyperbilirubinemia 
(4), respiratory insufficiency requiring ventilatory 
assistance in 2 patients, retrolental hyperplasia and 
methadone withdrawal in one patient each. All 
children are said to be developing normally and no 
congenital abnormalities were reported~ 
Discussion 
Transplantation has evolved as an accepted 
procedure for failed organs, but the long term effects 
of immunosuppression still remain a concern. Previous 
publications re~arding pregnancy following renal 
transplantation 8 - 10), have reported complications 
such as congenital abnormalities, adrenocortical 
inSUfficiency, infections, liver dysfunction and 
seizures. These patients were immunosuppressed with 
azathioprine and steroids, at dosages higher than 
those used today. only four patients received 
azathioprine as the main immunosuppressive agent. 
Although there were neonatal complications reported 
in one child (6), no long term sequelae were observed. 
cyclosporine has been shown to cross the placenta 
(11), and levels have been reported in the newborns 
born to mothers on CyA. Our report documents the use 
of this immunosuppressive agent in 18 patients who 
received liver transplantation without any significant 
adverse sequelae. FK506, the newest immunosuppressive 
agent was used in 3 patients, 2 of whom delivered 
babies. Both of these had a history of CyA use and 
received FK506 only for 2 weeks and 8 months prior to 
pregnancy. No valid conclusion can be drawn from the 
use of this agent in such short intervals of time. 
The risk of rejection does not appear to be 
increased during pregnancy, wi th only one case of 
acute rejection diagnosed by biopsy. Despite enzyme 
elevations seen, those not treated immediately 
underwent resolution along with those that received 
treatment. 30% of the patients had increasing hepatic 
enzyme activity in the antepartum period with 45% 
having alterations in the post-partum period. Again, 
spontaneous resolution occurred in 50% of cases. 
Overall, of 29 babies born to 22 liver transplant 
recipients, 60% of births occurred by cesarean 
delivery with a 88% incidence of prematurity seen in 
this group. Contributing factors were prelampsia, 
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premature rupture of membranes, and early fetal 
distress. Neonates born by NSVD sustained less 
maternal complications and were more normal in size, 
while 10% of babies delivered at full gestational age 
were small for gestational age. No congenital 
abnormalities were reported, and except for 3 infant 
deaths (10%), all others are reported to be alive and 
well. It is reasonable to assume that liver 
transplant recipients can still undergo a successful 
pregnancy, but it is not without risks. We suggest 
that careful monitoring be carried out by both a 
perinatologist and a transplant physician in order to 
minimize complications to both mother and child. 
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